DIAZEPAM PRODUCES PARTIAL GENERALIZATION TO THE DISCRIMINATIVE STIMULUS EFFECTS OF WAY-SEB-324, A 5-HT(1A) PARTIAL AGONIST/5-HT2 ANTAGONIST ANXIOLYTIC ANTIDEPRESSANT

被引：0
作者：
SHROPSHIRE, AT [1 ]
PIESLA, MJ [1 ]
MOYER, JA [1 ]
MARQUIS, KL [1 ]
机构：
[1] WYETH AYERST RES,PRINCETON,NJ 08543
来源：
FASEB JOURNAL | 1993年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A256 / A256
页数：1
相关论文
共 50 条
  • [41] CP-93,393: In vitro characterization of a novel anxiolytic/antidepressant agent with both 5-HT1A agonist and alpha-2 adrenergic antagonist properties.
    Schmidt, AW
    Fox, CB
    Jackson, ER
    Lazzaro, J
    McLean, S
    Ganong, A
    Zorn, SH
    Schulz, DW
    Desai, K
    Bright, GM
    Heym, J
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S38 - S38
  • [42] Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors.: Significance for the modulation of frontocortical monoaminergic transmission and depressive states
    Millan, MJ
    Newman-Tancredi, A
    Audinot, V
    Cussac, D
    Lejeune, F
    Nicolas, JP
    Cogé, F
    Galizzi, JP
    Boutin, JA
    Rivet, JM
    Dekeyne, A
    Gobert, A
    SYNAPSE, 2000, 35 (02) : 79 - 95
  • [43] Expression of the 5-HT1A Serotonin Receptor in the Hippocampus Is Required for Social Stress Resilience and the Antidepressant-Like Effects Induced by the Nicotinic Partial Agonist Cytisine
    Mineur, Yann S.
    Einstein, Emily B.
    Bentham, Matthew P.
    Wigestrand, Mattis B.
    Blakeman, Sam
    Newbold, Sylvia A.
    Picciotto, Marina R.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (04) : 938 - 946
  • [44] Expression of the 5-HT1A Serotonin Receptor in the Hippocampus Is Required for Social Stress Resilience and the Antidepressant-Like Effects Induced by the Nicotinic Partial Agonist Cytisine
    Yann S Mineur
    Emily B Einstein
    Matthew P Bentham
    Mattis B Wigestrand
    Sam Blakeman
    Sylvia A Newbold
    Marina R Picciotto
    Neuropsychopharmacology, 2015, 40 : 938 - 946
  • [45] MODIFICATION OF THE DISCRIMINATIVE STIMULUS EFFECTS OF 8-OH-DPAT, BUSPIRONE AND THE BETA-ADRENOCEPTOR ANTAGONIST PINDOLOL AFTER CHRONIC ADMINISTRATION OF THE 5-HT1A AGONIST 8-OH-DPAT IN THE PIGEON
    ZHANG, L
    BARRETT, JE
    BEHAVIOURAL PHARMACOLOGY, 1991, 2 (4-5): : 369 - 378
  • [46] PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions.: I.: Neurochemical effects
    Akunne, HC
    Zoski, KT
    Davis, MD
    Cooke, LW
    Meltzer, LT
    Whetzel, SZ
    Shih, YH
    Wustrow, DJ
    Wise, LD
    MacKenzie, RG
    Georgic, LM
    Heffner, TG
    Pugsley, TA
    NEUROPHARMACOLOGY, 2000, 39 (07) : 1197 - 1210
  • [47] PARTIAL AGONISTS OF THE HUMAN 5-HT(1A) RECEPTOR SELECTIVELY ACTIVATE G(I)ALPHA-2 AND G(I)ALPHA-3 WITH LESS EFFICACY THAN FULL AGONISTS
    GETTYS, TW
    FIELDS, TA
    RAYMOND, JR
    FASEB JOURNAL, 1993, 7 (07) : A1138 - A1138
  • [48] PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions.: II.: Preclinical behavioral effects
    Corbin, AE
    Meltzer, LT
    Ninteman, FW
    Wiley, JN
    Cristoffersen, CL
    Wustrow, DJ
    Wise, LD
    Pugsley, TA
    Heffner, TG
    NEUROPHARMACOLOGY, 2000, 39 (07) : 1211 - 1221
  • [49] Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]
    May, Jesse A.
    Sharif, Najam A.
    Chen, Hwang-Hsing
    Liao, John C.
    Kelly, Curtis R.
    Glennon, Richard A.
    Young, Richard
    Li, Jun-Xu
    Rice, Kenner C.
    France, Charles R.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 91 (03) : 307 - 314
  • [50] F15063, a compound with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (II) Activity in models of positive symptoms of schizophrenia
    Depoortere, R.
    Bardin, L.
    Auclair, A. L.
    Kleven, M. S.
    Prinssen, E.
    Colpaert, F.
    Vacher, B.
    Newman-Tancredi, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (02) : 253 - 265
12345